239
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Application of graphene and mesoporous silica nanomaterials on the orthopaedic implants: recent advances

&
Pages 806-811 | Received 12 Aug 2016, Accepted 27 Aug 2016, Published online: 16 Sep 2016

References

  • T. Sherman: ‘Feds end oversight of orthopaedic implant companies’, 2009. Available from: www.nj.com/news/index.ssf/2009/03/feds_end_oversight_of_orthoped.html
  • T. E. Sehlinger and D. Seligson: ‘Clinical and laboratory performance of bone plates’, (ed. J. P. Harvey and R. F. Games), 1217–1218; 1994, Philadelphia, PA, ASTM STP.
  • T. M. Wright and S. B. Goodman, Ed., ‘Implant Wear in Total Joint Replacement’, Symposium Oakbrook, IL, American Academy of Orthopaedic Surgeons. October 2000, 195.
  • H. Malchau, P. Herberts, T. Eisler, G. Garellick, and P. S€oderman: ‘The swedish total hip replacement register’, J. Bone Joint Surg., 2002, 84-A, 2–20, 84-A, 2–20.
  • L. Montanaro, D. Campoccia and C. R. Arciola: ‘Nanostructured materials for inhibition of bacterial adhesion in orthopaedic implants: a minireview’, Int. J. Artif. Organs, 2008, 31, 771–776.
  • J. Groll, J. Fiedler, K. Bruellhoff, M. Moeller and R. E. Brenner: ‘Novel surface coatings modulating eukaryotic cell adhesion and preventing implant infection’, Int. J. Artif. Organs, 2009, 32, 655–662.
  • K. G. Neoh, X. Hu, D. Zheng and E. T. Kang: ‘Balancing osteoblast functions and bacterial adhesion on functionalized titanium surfaces’, Biomaterials, 2012, 33, 2813–2822.10.1016/j.biomaterials.2012.01.018
  • K. L. Garvin, J. A. Miyano, D. Robinson, D. Giger, J. Novak and S. Radio: ‘Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model’, J. Bone Joint Surg., 1994, 76, 1500–1506.
  • H. Gollwitzer, K. Ibrahim, H. Meyer, W. Mittelmeier, R. Busch and A. Stemberger: ‘Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology’, J. Antimicrob. Chemother., 2003, 51, 585–591.10.1093/jac/dkg105
  • T. Kälicke, J. Schierholz, U. Schlegel, T. M. Frangen, M. Köller, G. Printzen, D. Seybold, S. Klöckner, G. Muhr and S. Arens: ‘Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study’, J. Orthop. Res., 2006, 24, 1622–1640.10.1002/(ISSN)1554-527X
  • G. Schmidmaier, M. Lucke, B. Wildemann, N. P. Haas and M. Raschke: ‘Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review’, Injury, 2006, 37, S1051–S1112.
  • J. Wei, X. Wu, C. Liu, J. Jia, S. J. Heo, S. E. Kim, Y. T. Hyun and J. W. Shin: ‘Fabrication of bioactive scaffold of poly(E-caprolactone) and nanofiber wollastonite composite’, J. Am. Ceram. Soc., 2009, 92, 1017–1023.10.1111/jace.2009.92.issue-5
  • J. Wei, J. Lu, Y. Yan, H. Li, J. Ma, X. Wu, C. Dai and C. Liu: ‘Preparation and characterization of well ordered mesoporous diopside nanobiomaterial’, J. Nanosci. Nanotechnol., 2011, 11, 10746–10749.10.1166/jnn.2011.3940
  • Y. Ikada: ‘Surface modification of polymers for medical applications’, Biomaterials, 1994, 15, 725–736.10.1016/0142-9612(94)90025-6
  • M. H. Zablotsky: ‘Hydroxyapatite coatings in implant dentistry’, Implant Dent., 1992, 1, 253–257.10.1097/00008505-199200140-00004
  • L. G. Yu, K. A. Khor, H. Li and P. Cheang: ‘Effect of spark plasma sintering on the microstructure and in vitro behavior of plasma sprayed HA coatings’, Biomaterials, 2003, 24, 2695–2705.10.1016/S0142-9612(03)00082-6
  • D. Lahiri, S. Ghosh and A. Agarwal: ‘Carbon nanotube reinforced hydroxyapatite composite for orthopaedic application: a review’, Mater. Sci. Eng. C, 2012, 32, 1727–1758.10.1016/j.msec.2012.05.010
  • M. Kalbacova, A. Broz, J. Kong and M. Kalbac: ‘Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells’. Carbon, 2010, 48, 4323–4329.10.1016/j.carbon.2010.07.045
  • W. B. Hu, C. Peng, W. J. Luo, M. Lv, X. M. Li and D. Li: ‘Graphene based antibacterial paper’, ACS Nano, 2010, 4, 4317–4323.10.1021/nn101097v
  • H. Y. Liu, P. X. Xi, G. Q. Xie, Y. J. Shi, F. P. Hou and L. Huang: ‘Simultaneous reduction and surface functionalization of graphene oxide for hydroxyapatite mineralization’, J. Phys. Chem. C, 2012, 116, 3334–3341.10.1021/jp2102226
  • L. Zhang, L. Weiwei, C. Yue, T. Zhang, P. Li, Z. Xing and Y. Chen: ‘A tough graphene nanosheet/hydroxyapatite composite with improved in vitro biocompatibility’, Carbon, 2013, 61, 105–115.
  • M. Brewer, T. Zhang, W. Dong, M. Rutherford and Z. R. Tian: ‘Future approaches of nanomedicine in clinical science’, Med. Clin. Am., 2007, 91, 963–1016.10.1016/j.mcna.2007.05.006
  • H. S. Nalwa: ‘Handbook of nanostructured materials and nanotechnology’, Vols. 1–5, 2000, San Diego, CA, Academic Press.
  • H. S. Nalwa: ‘Encyclopedia of nanoscience and nanotechnology’, Vols. 1–25, (2004/2011), Los Angeles, CA, American Scientific Publishers.
  • P. Giannoudis, H. Dinopoulos and E. Tsiridis: ‘Bone substitutes: an update’, Injury, 2005, 36, 20–27.10.1016/j.injury.2005.07.029
  • D. Bitounis, H. Ali-Boucetta, B. H. Hong, D. H. Min and K. Kostarelos: ‘Prospects and challenges of graphene in biomedical applications’, Adv. Mater., 2013, 25, 2258–2268.10.1002/adma.201203700
  • C. Chung, Y. K. Kim, D. Shin, S. R. Ryoo, B. H. Hong and D. H. Min: ‘Biomedical applications of graphene and graphene oxide’, Acc. Chem. Res., 2013, 46, 2211–2224.10.1021/ar300159f
  • H. Kim, A. A. Abdala and C. W. Macosko: ‘Graphene/polymer nanocomposites’, Macromolecules, 2010, 43, 6515–6530.10.1021/ma100572e
  • H. Shen, L. Zhang, M. Liu and Z. Zhang: ‘Biomedical applications of graphene’, Theranostics, 2012, 2, 283–294.10.7150/thno.3642
  • M. Kalbacova, A. Broz, J. Kong and M. Kalbac: ‘Graphene substrates promote adherence of human osteoblasts and mesenchymal stromal cells’, Carbon, 2010, 48, 4323–4329.10.1016/j.carbon.2010.07.045
  • H. Fan, L. Wang, K. Zhao, N. Li, Z. Shi, Z. Ge and Z. Jin: ‘Fabrication, mechanical properties, and biocompatibility of graphene-reinforced chitosan composites’, Biomacromolecules, 2010, 11, 2345–2351.10.1021/bm100470q
  • A. Oyefusi, O. Olanipekun, G. M. Neelgund, D. Peterson, J. M. Stone, E. Williams, L. Carson, G. Regisford and A. Oki: ‘Hydroxyapatite grafted carbon nanotubes and graphene nanosheets: promising bone implant materials’, Spectrochim. Acta A Mol. Biomol. Spectrosc., 2014, 132, 410–416.10.1016/j.saa.2014.04.004
  • C. Zhao, X. Lu, C. Zanden and J. Liu: ‘The promising application of graphene oxide as coating materials in orthopaedic implants: preparation, characterization and cell behavior’, Biomed. Mater., 2015, 10, 015019.10.1088/1748-6041/10/1/015019
  • F. Mohandes and M. Salavati-Niasari: ‘Freeze-drying synthesis, characterization and in vitro bioactivity of chitosan/graphene oxide/hydroxyapatite nanocomposite’, RSC Adv., 2014, 4, 25993–26001.10.1039/c4ra03534h
  • F. Mohandes and M. Salavati-Niasari: ‘In vitro comparative study of pure hydroxyapatite nanorods and novel polyethylene glycol/graphene oxide/hydroxyapatite nanocomposite’, J. Nanopart. Res., 2014, 16, 2604–2616.10.1007/s11051-014-2604-y
  • L. Ming, L. Qian, J. Zhaojun, X. Xuchen, S. Yuying, C. Yan, Z. Yufeng, X. Tingfei and W. Shicheng: ‘Electrophoretic deposition and electrochemical behavior of novel graphene oxide-hyaluronic acidhydroxyapatite nanocomposite coatings’, Appl. Surf. Sci., 2013, 284, 804–810.
  • A. Janković, S. Eraković, M. Vukašinović-Sekulić, V. Mišković-Stanković, S. Park, K. Rhee: ‘Graphene-based antibacterial composite coatings electrodeposited ontitanium for biomedical applications’, Prog. Org. Coat., 2015, 83, 1–10.10.1016/j.porgcoat.2015.01.019
  • W. Hu, C. Peng, W. Luo, M. Lv, X. Li, D. Li, Q. Huang and C. Fan: ‘Graphene-based antibacterial paper’, ACS Nano, 2010, 4, 4317–4323.10.1021/nn101097v
  • Y. Chang, S. T. Yang, J. H. Liu, E. Dong, Y. Wang, A. Cao, Y. Liu and H. Wang: ‘In vitro toxicity evaluation of graphene oxide on A549 cells’, Toxicol. Lett., 2011, 200, 201–210.10.1016/j.toxlet.2010.11.016
  • C. Kosanović, G. Falini and D. Kralj: ‘Mineralization of calcium carbonates in gelling media’, Cryst. Growth Des., 2011, 11, 269–277.10.1021/cg1012796
  • A. Eftekhari, ‘Nanostructured Materials in Electrochemistry’, Weinheim, Wiley-VCH, 2008.
  • I. I. Slowing, J. L. Vivero-Escoto, C. W. Wu and V. S. Y. Lin: ‘Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers’, Adv. Drug Delivery Rev., 2008, 60, 1278–1288.10.1016/j.addr.2008.03.012
  • F. Tang, L. Y. Li and D. Chen: ‘Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery’, Adv. Mater., 2012, 24, 1504–1534.10.1002/adma.201104763
  • M. S. Bradbury, E. Phillips, P. H. Montero and S. M. ChealH. Stambuk, J. C. Durack, C.T. Sofocleous, R. J. C. Meester, U. Wiesner and S. Patel: ‘Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions’, Integr. Biol., 2013, 5, 74–86.10.1039/C2IB20174G
  • R. Mellaerts, R. Mols and J. A. G. Jammaer: ‘Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica’, Eur. J. Pharm. Biopharm., 2008, 69, 223–230.10.1016/j.ejpb.2007.11.006
  • M. Vallet-Regi, F. Balas and M. Colilla: ‘Bone-regenerative bioceramic implants with drug and protein controlled delivery capability’, Progr. Solid State Chem., 2008, 36, 163–191.10.1016/j.progsolidstchem.2007.10.002
  • C. Dai, Y. Yuan and C. Liu: ‘Degradable, antibacterial silver exchanged mesoporous silica spheres for hemorrhage control’, Biomaterials, 2009, 30, 5364–5375.10.1016/j.biomaterials.2009.06.052
  • T. López, E. I. Basaldella and M. J. Ojeda: ‘Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lope epilepsy’, Optical Materials, 2006, 29, 75–81.10.1016/j.optmat.2006.03.017
  • Food Drug Administration (E. FIarrison). ‘Generally recognized as safe determination for silicon dioxide when added directly and/or indirectly to human food; silicon dioxide GRAS notification’, Boston, MA, 2010, available at [http://www.fda.gov/ucm/groups/fdagovpublic/@fdagovfoodsgen/documents/document/ucm269494.pdf], (accessed [2 November 2014]).
  • Q. J. He and J. L. Shi: ‘Mesoporous silica nanoparticle based nano drug delivery systems: synthesis, controlled drug release and delivery, pharmacokinetics and biocompatibility’, J. Mater. Chem., 2011, 21, 5845–5855.10.1039/c0jm03851b
  • L. Zongxi, C. B. Jonathan, B. Aleksandr, J. Fraser Stoddart and J. I. Zink: ‘Mesoporous silica nanoparticles in biomedical applications’, Chem. Soc. Rev., 2012, 41, 2590–2605.
  • H. Meng, M. Xue, T. Xia, Z. Ji, D. Y. Tarn, J. I. Zink and A. E. Nel: ‘Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model’, ACS Nano, 2011, 5, 4131–4144.10.1021/nn200809t
  • I. Kempf, A. Grosse and G. Beck: ‘Closed locked intramedullary nailing. Its application to comminuted fractures of the femur’. J. Bone Joint Surg. Am., 1985, 67, 709–720.
  • S. Grote, W. Boecker, W. Mutschler and M. Schieker: ‘Current aspects of fragility fracture repair’, Eur. J. Trauma Emerg. Surg., 2008, 34, 535–541.10.1007/s00068-008-8207-5
  • M. Zhu, Y. Zhu, B. Ni, N. Xie, X. Lu, J. Shi, Y. Zeng and X. Guo: ‘Mesoporous silica nanoparticles/hydroxyapatite composite coated implants to locally inhibit osteoclastic activity’. ACS Appl. Mater. Interface, 2014, 6, 5456–5466.10.1021/am405013t
  • A. Braem, K. De Cremer, N. Delattin, K. De Brucker, B. Neirinck and K. Vandamme: ‘Novel anti-infective implant substrates: controlled release of antibiofilm compounds from mesoporous silica-containing macroporous titaniu’, Colloids Surf. B Biointerfaces, 2015, 126, 481–488.10.1016/j.colsurfb.2014.12.054
  • J. E. Valdez-García, A. Climent, E. Chávez-Mondragón and J. F. Lozano-Ramírez: ‘Anterior chamber bacterial contamination in cataract surgery’, BMC Ophthalmol., 2014, 14, 6–63.10.1186/1471-2415-14-57
  • H. Tan, S. Guo, S. Yang, X. Xu and T. Tang: ‘Physical characterization and osteogenic activity of the quaternized chitosan-loaded PMMA bone cement’. Acta Biomater., 2012, 8, 2166–2174.10.1016/j.actbio.2012.03.013
  • L. R. Martinez, M. R. Mihu, M. Tar, R. J. Cordero, G. Han and A. J. Friedman: ‘Demonstration of antibiofilm and antifungal efficacy of chitosan against candidal biofilms, using an in vivo central venous catheter model’, J. Infect. Dis., 2010, 201, 1436–1440.10.1086/651175
  • P. K. Dutta, J. Dutta and V. S. Tripathi: ‘Chitin and chitosan: chemistry, properties and applications’. J. Sci. Ind. Res. India, 2004, 63, 20–31.
  • P. Y. Zhou, Y. Xia, J. Wang, C. Liang, L. Yu and W. Tang: ‘Antibacterial properties and bioactivity of HACC- and HACC-Zein-modified mesoporous bioactive glass scaffolds’. J. Mater. Chem. B, 2013, 1, 685–692.10.1039/C2TB00102K

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.